{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:01:32Z","timestamp":1773288092375,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p><jats:italic>Ganoderma<\/jats:italic> extracts have the potential to be used as anti-cancer, anti-inflammatory, immunomodulator, and antimicrobial agents, as evaluated in numerous studies. This study was aimed to determine the lethal and inhibitory effects of aqueous, hydroalcoholic, and alcoholic extracts of <jats:italic>Ganoderma lucidum<\/jats:italic> on <jats:italic>Toxoplasma gondii<\/jats:italic> RH strain tachyzoites, <jats:italic>in vitro<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All three types of extracts showed toxoplasmacidal effects. The highest percentage of mortality was related to hydroalcoholic extract. The EC50 of <jats:italic>Ganoderma<\/jats:italic> extracts for tachyzoites were 76.32, 3.274, and 40.18 for aqueous, hydroalcoholic and alcoholic extracts, respectively. The selectivity index obtained for hydroalcoholic extract was 71.22, showing the highest activity compared to other extracts. According to our findings, the hydroalcoholic part was the most effective substance among the extracts. This basic study showed obvious anti-toxoplasma effect of <jats:italic>Ganoderma lucidum<\/jats:italic> extracts. These extracts can be used as candidates for further in-depth and comprehensive studies especially <jats:italic>In vivo<\/jats:italic> experiments to prevent toxoplasmosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-023-06355-6","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:02:07Z","timestamp":1684411327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In vitro anti-Toxoplasma gondii activity of Ganoderma lucidum extracts"],"prefix":"10.1186","volume":"16","author":[{"given":"Mohammad","family":"ahmadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboobeh","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrzad","family":"Saraei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloofar Salavati","family":"Nezhad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Javadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faezeh","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peyman","family":"Heydarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2159-4066","authenticated-orcid":false,"given":"Elham","family":"Hajialilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"6355_CR1","unstructured":"Dubey JP. Toxoplasmosis of animals and humans, ed. t. ed. 2010: Boca Raton, FL: CRC Press."},{"issue":"3","key":"6355_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/pathogens7030069","volume":"7","author":"LA Caldas","year":"2018","unstructured":"Caldas LA, De Souza W. A window to Toxoplasma gondii egress. Pathogens. 2018;7(3):69.","journal-title":"Pathogens"},{"issue":"12\u201313","key":"6355_CR3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","volume":"30","author":"AM Tenter","year":"2000","unstructured":"Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12\u201313):1217\u201358.","journal-title":"Int J Parasitol"},{"issue":"3","key":"6355_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.amjmed.2004.08.023","volume":"118","author":"JD Kravetz","year":"2005","unstructured":"Kravetz JD, Federman DG. Toxoplasmosis in pregnancy. Am J Med. 2005;118(3):212\u20136.","journal-title":"Am J Med"},{"issue":"3","key":"6355_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1128\/MMBR.64.3.607-623.2000","volume":"64","author":"MW Black","year":"2000","unstructured":"Black MW, Boothroyd JC. Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev. 2000;64(3):607\u201323.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"3","key":"6355_CR6","doi-asserted-by":"publisher","first-page":"e90203","DOI":"10.1371\/journal.pone.0090203","volume":"9","author":"J Flegr","year":"2014","unstructured":"Flegr J, et al. Toxoplasmosis\u2013a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS ONE. 2014;9(3):e90203.","journal-title":"PLoS ONE"},{"key":"6355_CR7","unstructured":"Dubey J. Toxoplasmosis in man (Homo sapiens) Toxoplasmosis of animals and man, 1988: p.\u00a041\u201359."},{"issue":"1","key":"6355_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4732-z","volume":"12","author":"DA Abugri","year":"2019","unstructured":"Abugri DA, Jaynes JM, Witola WH. Anti-toxoplasma activity of Sorghum bicolor-derived lipophilic fractions. BMC Res Notes. 2019;12(1):1\u20137.","journal-title":"BMC Res Notes"},{"key":"6355_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/DDDT.S60973","volume":"11","author":"PH Alday","year":"2017","unstructured":"Alday PH, Doggett JS. Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Des Devel Ther. 2017;11:273.","journal-title":"Drug Des Devel Ther"},{"key":"6355_CR10","doi-asserted-by":"crossref","unstructured":"Montazeri M et al. A systematic review of in vitro and in vivo activities of anti-toxoplasma drugs and compounds (2006\u20132016). Frontiers in microbiology, 2017: p. 25.","DOI":"10.3389\/fmicb.2017.00025"},{"issue":"1","key":"6355_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0002-9394(02)01537-4","volume":"134","author":"LH Bosch-Driessen","year":"2002","unstructured":"Bosch-Driessen LH, et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol. 2002;134(1):34\u201340.","journal-title":"Am J Ophthalmol"},{"key":"6355_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jep.2017.08.041","volume":"210","author":"R-l Zhao","year":"2018","unstructured":"Zhao R-l, He Y-m. Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL\/6 mice. J Ethnopharmacol. 2018;210:287\u201395.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"6355_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/1534735414568721","volume":"14","author":"S Cheng","year":"2015","unstructured":"Cheng S, Sliva D. Ganoderma lucidum for cancer treatment: we are close but still not there. Integr cancer Ther. 2015;14(3):249\u201357.","journal-title":"Integr cancer Ther"},{"key":"6355_CR14","doi-asserted-by":"crossref","unstructured":"Ghobadi R et al. Effect of Ganoderma lucidum powder on oxidative stability, microbial and sensory properties of emulsion type sausage. Adv Biomedical Res, 2018. 7.","DOI":"10.4103\/2277-9175.225595"},{"issue":"Suppl 1","key":"6355_CR15","first-page":"S248","volume":"6","author":"RN Nayak","year":"2015","unstructured":"Nayak RN, et al. Evaluation of anti-microbial activity of spore powder of Ganoderma lucidum on clinical isolates of Prevotella intermedia: a pilot study. Contemp Clin Dent. 2015;6(Suppl 1):S248.","journal-title":"Contemp Clin Dent"},{"issue":"2","key":"6355_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1081\/FRI-200051893","volume":"21","author":"Y Gao","year":"2005","unstructured":"Gao Y, et al. Antimicrobial activity of the medicinal mushroom Ganoderma. Food Reviews International. 2005;21(2):211\u201329.","journal-title":"Food Reviews International"},{"key":"6355_CR17","doi-asserted-by":"crossref","unstructured":"Oluba OM et al. Modulation of lipoprotein cholesterol levels in Plasmodium berghei malarial infection by crude aqueous extract of Ganoderma lucidum Cholesterol, 2012. 2012.","DOI":"10.1155\/2012\/536396"},{"issue":"511","key":"6355_CR18","first-page":"1628","volume":"36","author":"S Akbari","year":"2019","unstructured":"Akbari S, et al. Evaluation of Antileishmanial Effect of Hydroalcoholic Extract of Ganoderma Leucidum on Leishmania Major in Vitro. J Isfahan Med School. 2019;36(511):1628\u201334.","journal-title":"J Isfahan Med School"},{"issue":"6","key":"6355_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.joim.2020.08.002","volume":"18","author":"OM Oluba","year":"2020","unstructured":"Oluba OM, et al. Effects of co-administration of Ganoderma terpenoid extract with chloroquine on inflammatory markers and antioxidant status in Plasmodium berghei-infected mice. J Integr Med. 2020;18(6):522\u20139.","journal-title":"J Integr Med"},{"key":"6355_CR20","doi-asserted-by":"crossref","unstructured":"Oluba OM et al. Antimalarial and hepatoprotective effects of crude ethanolic extract of lingzhi or reishi medicinal mushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst.(higher Basidiomycetes), in Plasmodium berghei-infected mice. Int J Med Mushrooms, 2012. 14(5).","DOI":"10.1615\/IntJMedMushr.v14.i5.30"},{"key":"6355_CR21","unstructured":"Akbari; S et al. Evaluation of Antileishmanial Effect of Hydroalcoholic Extract of Ganoderma Leucidum on Leishmania Major in Vitro. J Isfahan Med School, 2019. 36."},{"key":"6355_CR22","unstructured":"Javadi F et al. Study on anti-Toxoplasma effects of Myrtus communis and Artemisia aucheri Boiss extracts 2017."},{"issue":"1","key":"6355_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3831\/KPI.2016.19.009","volume":"19","author":"S Nozari","year":"2016","unstructured":"Nozari S, et al. Ethanol extracts of Achillea millefolium and Hypericum perforatum low anti-toxoplasma activity. J Pharmacopunct. 2016;19(1):70.","journal-title":"J Pharmacopunct"},{"issue":"5","key":"6355_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1021\/np100031c","volume":"73","author":"M Adams","year":"2010","unstructured":"Adams M, et al. Antiplasmodial lanostanes from the Ganoderma lucidum mushroom. J Nat Prod. 2010;73(5):897\u2013900.","journal-title":"J Nat Prod"},{"issue":"3","key":"6355_CR25","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4314\/jpb.v18i3.1","volume":"18","author":"SO Ede","year":"2021","unstructured":"Ede SO, et al. Anti-trypanosomal, antioxidant and antimicrobial activities of the fruiting bodies of Ganoderma lucidum (W. Curt.: Fr)(Ganodermataceae) aqueous extract. J Pharm Bioresources. 2021;18(3):172\u201381.","journal-title":"J Pharm Bioresources"},{"issue":"4","key":"6355_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s13596-017-0288-4","volume":"17","author":"OM Oluba","year":"2017","unstructured":"Oluba OM, et al. Antiplasmodial and antioxidant activities of chloroform extract of Ganoderma lucidum fruit body in Plasmodium berghei-infected mice. Orient Pharm Experimental Med. 2017;17(4):389\u201395.","journal-title":"Orient Pharm Experimental Med"},{"key":"6355_CR27","doi-asserted-by":"crossref","unstructured":"Oluba OM et al. Modulatory Effect of Crude Aqueous Extract of Lingzhi or Reishi Medicinal mushroom, Ganoderma lucidum (higher Basidiomycetes), on hematological and antioxidant indices in Plasmodium berghei \u2013 infected mice. Int J Med mushrooms, 2014. 16(5).","DOI":"10.1615\/IntJMedMushrooms.v16.i5.90"},{"key":"6355_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.phytochem.2014.10.011","volume":"114","author":"IC Ferreira","year":"2015","unstructured":"Ferreira IC, et al. Chemical features of Ganoderma polysaccharides with antioxidant, antitumor and antimicrobial activities. Phytochemistry. 2015;114:38\u201355.","journal-title":"Phytochemistry"},{"issue":"2","key":"6355_CR29","first-page":"983","volume":"5","author":"R Kamble","year":"2011","unstructured":"Kamble R, Venkata S, Gupte A. Antimicrobial activity of Ganoderma lucidum mycelia. J Pure Appl Microbiol. 2011;5(2):983\u20136.","journal-title":"J Pure Appl Microbiol"},{"issue":"11","key":"6355_CR30","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3923\/ijps.2009.1052.1057","volume":"8","author":"A Ogbe","year":"2009","unstructured":"Ogbe A, et al. Potential of a wild medicinal mushroom, Ganoderma sp., as feed supplement in chicken diet: effect on performance and health of pullets. Int J Poult Sci. 2009;8(11):1052\u20137.","journal-title":"Int J Poult Sci"},{"issue":"2","key":"6355_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.31989\/ffhd.v3i2.65","volume":"3","author":"C Kao","year":"2013","unstructured":"Kao C, et al. Anti-cancer activities of Ganoderma lucidum: active ingredients and pathways. Funct Foods health Disease. 2013;3(2):48\u201365.","journal-title":"Funct Foods health Disease"},{"issue":"6","key":"6355_CR32","first-page":"3708","volume":"3","author":"R Anshumali","year":"2012","unstructured":"Anshumali R, et al. Biochemical estimation of wildly collected Ganoderma lucidum from Central Himalayan Hills of India. Adv Appl Sci Res. 2012;3(6):3708\u201313.","journal-title":"Adv Appl Sci Res"},{"issue":"1","key":"6355_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3906\/bot-1302-39","volume":"38","author":"R Singh","year":"2014","unstructured":"Singh R, Dhingra GS, Shri R. A comparative study of taxonomy, physicochemical parameters, and chemical constituents of Ganoderma lucidum and G. philippii from Uttarakhand, India. Turkish J Bot. 2014;38(1):186\u201396.","journal-title":"Turkish J Bot"},{"key":"6355_CR34","doi-asserted-by":"crossref","unstructured":"Buddha B, Basneta et al. Current and future perspective on antimicrobial and anti-parasitic activities of Ganoderma sp.: an update. MYCOLOGY, 2017. 8.","DOI":"10.1080\/21501203.2017.1324529"},{"issue":"6","key":"6355_CR35","first-page":"2337","volume":"5","author":"R Richa Rathor","year":"2014","unstructured":"Richa Rathor R, Tulsawani, Misra K. HYDRO-ETHANOLIC EXTRACT OF GANODERMA LUCIDUM (HEGL) SHOWS ANTIINFLAMMATORY ACTIVITY ON THP1 CYTOKINES AND NF-kB P65 RESPONSE. Int J Pharm Sci Res. 2014;5(6):2337\u201348.","journal-title":"Int J Pharm Sci Res"},{"issue":"3","key":"6355_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/medicines5030078","volume":"5","author":"EE Bach","year":"2018","unstructured":"Bach EE, et al. Hypoglicemic and hypolipedimic effects of Ganoderma lucidum in streptozotocin-induced diabetic rats. Medicines. 2018;5(3):78.","journal-title":"Medicines"},{"issue":"3","key":"6355_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1504\/IJLR.2011.046168","volume":"8","author":"F Martin","year":"2011","unstructured":"Martin F, Nair CKK. Medicinal fungus Ganoderma lucidum protects cellular DNA in mice exposed to whole-body gamma radiation. Int J Low Radiation. 2011;8(3):241\u201353.","journal-title":"Int J Low Radiation"},{"key":"6355_CR38","doi-asserted-by":"crossref","unstructured":"Montazeri M et al. Anti-Toxoplasma activities of the hydroalcoholic extract of some brassicaceae species. Adv Biomedical Res, 2020. 9.","DOI":"10.4103\/abr.abr_206_19"},{"issue":"4","key":"6355_CR39","first-page":"631","volume":"16","author":"M Jafari","year":"2021","unstructured":"Jafari M, et al. Anti-Toxoplasma Effect of Hydroalchohlic Extract of Terminalia chebula Retz in Cell Culture and Murine Model. Iran J Parasitol. 2021;16(4):631.","journal-title":"Iran J Parasitol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-023-06355-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-023-06355-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-023-06355-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:03:48Z","timestamp":1684411428000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-023-06355-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6355"],"URL":"https:\/\/doi.org\/10.1186\/s13104-023-06355-6","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"assertion":[{"value":"8 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedure implemented in the present research project was fully reviewed and approved by the Research Ethics Committee of Qazvin University of Medical Sciences (Code no: IR.QUMS.REC.1400.165).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}